OOIR: Observatory of International Research

Papers

(The TQCC of Endocrinology and Metabolism Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Forthcoming Issues	227
Forthcoming Issues	158
Copyright	72
Type 1 Diabetes	66
Abnormal Puberty Revisited: A Practical Approach	51
Precocious and Delayed Puberty Revisited	48
Treatment of Central Precocious Puberty with a Focus on Girls	42
Hormone Therapy During Infancy or Early Childhood for Patients with Hypogonadotropic Hypogonadism, Klinefelter or Turner Syndrome	41
Diabetes and Osteoporosis	37
Updates on Osteoporosis	31
Remission with an Intervention	29
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge	25
Disparities in Thyroid Care	23
Lean Metabolic-Associated Fatty Liver Disease	23
Can the Future be Bright with Advances in Diabetic Eye Care?	21
Updates in Thyroidology	19
Recognizing and Addressing Health Inequities in Endocrinology and Diabetes	19
Contents	17
Optimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men	17
Rekindling Hope for Remission	16
Contents	16
Novel Therapeutics for Advanced Differentiated Thyroid Cancer	16
Copyright	15
Metabolic-Associated Fatty Liver Disease	14
Contributors	14

Copyright	14
Contents	14
Disparities in Access to High-Volume Surgeons and Specialized Care	14
Presentation and Care for Children with Peripheral Precocious Puberty	13
The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men	13
Update on Preeclampsia and Hypertensive Disorders of Pregnancy	13
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents	12
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease	12
Prevention of Type 2 Diabetes	12
Updates on Osteoporosis in Men	11
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia	11
Hypercalcemia Associated with Pregnancy and Lactation	11
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes	11
Lipid Disorders and Metabolic-Associated Fatty Liver Disease	10
Evaluation and Management of Thyrotoxicosis During Pregnancy	10
Pathophysiology of Hypercalcemia	10
Prolactinomas	10
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone	10
Endocrine Disorders During Pregnancy	10
Osteoporosis: Update on Diagnosis and Management	9
Age-Associated Abnormalities of Water Homeostasis	9
Postmenopausal Osteoporosis	9
Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis	9
Assessment of Skeletal Strength	8
Pathobiology of Metabolic-Associated Fatty Liver Disease	7
Postmenopausal Osteoporosis	7
Normal Puberty	7
Glucocorticoid- and Transplantation-Induced Osteoporosis	7
Advancing Obesity Medicine	7
Role of Bone Turnover Markers in Osteoporosis Therapy	7
Type 1 Diabetes and Aging	7
The Changing Nature of Mortality and Morbidity in Patients with Diabetes	7
Contents	6
Forthcoming Issues	6
Contributors	6
Forthcoming Issues	6
Testosterone Treatment and the Risk of Prostate Adverse Events	6
LDL Cholesterol—How Low Can We Go?	6
Pandemic of Diabetes and Prediabetes: Prevention and Control	6
Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes	6
Contents	6
The Inherited Hypercholesterolemias	6
Untamed Pandemic of Diabetes: 100 years After the Discovery of Insulin	6
Lipid Disorders and Pregnancy	6
Updates on Osteoporosis	5
Hereditary Primary Hyperparathyroidism	5
Importance of Patient-Reported Outcomes in Endocrinology	5
Copyright	5
Forthcoming Issues	5
Contributors	5

Update on Lipids and Lipoproteins	5
Contributors	5
Contents	5
Copyright	5
Why Focus on Androgens in Women?	5
The Evolving Landscape of Type 1 Diabetes Management	5
Patient-Reported Outcomes in Endocrine Diseases	5